Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice

被引:96
作者
Mayr, M
Metzler, B
Chung, YL
McGregor, E
Mayr, U
Troy, H
Hu, YH
Leitges, M
Pachinger, O
Griffiths, JR
Dunn, MJ
Xu, QB
机构
[1] St George Hosp, Sch Med, Dept Cardiac & Vasc Sci, London SW17 0RE, England
[2] St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England
[3] Univ Innsbruck Hosp, Dept Internal Med, Div Cardiol, A-6020 Innsbruck, Austria
[4] Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany
[5] Kings Coll London, Inst Psychiat, London SE5 8AF, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2004年 / 287卷 / 02期
关键词
protein kinase C; proteomics; metabolomics; ischemia-reperfusion; mouse model;
D O I
10.1152/ajpheart.00878.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ischemic preconditioning confers cardiac protection during subsequent ischemia-reperfusion, in which protein kinase C (PKC) is believed to play an essential role, but controversial data exist concerning the PKC-delta isoform. In an accompanying study (26), we described metabolic changes in PKC-delta knockout mice. We now wanted to explore their effect on early preconditioning. Both PKC-delta(-/-) and PKC-delta(+/+) mice underwent three cycles of 5-min left descending artery occlusion/5-min reperfusion, followed by 30-min occlusion and 2-h reperfusion. Unexpectedly, preconditioning exaggerated ischemia-reperfusion injury in PKC-delta(-/-) mice. Whereas ischemic preconditioning increased superoxide anion production in PKC-delta(+/+) hearts, no increase in reactive oxygen species was observed in PKC-delta(-/-) hearts. Proteomic analysis of preconditioned PKC-delta(+/+) hearts revealed profound changes in enzymes related to energy metabolism, e.g., NADH dehydrogenase and ATP synthase, with partial fragmentation of these mitochondrial enzymes and of the E-2 component of the pyruvate dehydrogenase complex. Interestingly, fragmentation of mitochondrial enzymes was not observed in PKC-delta(-/-) hearts. High-resolution NMR analysis of cardiac metabolites demonstrated a similar rise of phosphocreatine in PKC-delta(+/+) and PKC-delta(-/-) hearts, but the preconditioning-induced increase in phosphocholine, alanine, carnitine, and glycine was restricted to PKC-delta(+/+) hearts, whereas lactate concentrations were higher in PKC-delta(-/-) hearts. Taken together, our results suggest that reactive oxygen species generated during ischemic preconditioning might alter mitochondrial metabolism by oxidizing key mitochondrial enzymes and that metabolic adaptation to preconditioning is impaired in PKC-delta(-/-) hearts.
引用
收藏
页码:H946 / H956
页数:11
相关论文
共 53 条
[1]  
[Anonymous], 1974, METHODS ENZYMATIC AN
[2]   Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1 [J].
Arrell, DK ;
Neverova, I ;
Fraser, H ;
Marbán, E ;
Van Eyk, JE .
CIRCULATION RESEARCH, 2001, 89 (06) :480-487
[3]   Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining [J].
Birnbaum, Y ;
Hale, SL ;
Kloner, RA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (02) :657-666
[4]   The late phase of preconditioning [J].
Bolli, R .
CIRCULATION RESEARCH, 2000, 87 (11) :972-983
[5]  
Brooks G, 1996, CIRC RES, V79, P627
[6]   A REDOX-BASED MECHANISM FOR CARDIOPROTECTION INDUCED BY ISCHEMIC PRECONDITIONING IN PERFUSED RAT-HEART [J].
CHEN, W ;
GABEL, S ;
STEENBERGEN, C ;
MURPHY, E .
CIRCULATION RESEARCH, 1995, 77 (02) :424-429
[7]   B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening [J].
D'Souza, SP ;
Yellon, DM ;
Martin, C ;
Schulz, R ;
Heusch, G ;
Onody, A ;
Ferdinandy, P ;
Baxter, GF .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05) :H1592-H1600
[8]   Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport [J].
da Silva, MM ;
Sartori, A ;
Belisle, E ;
Kowaltowski, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01) :H154-H162
[9]   Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation [J].
Dorn, GW ;
Souroujon, MC ;
Liron, T ;
Chen, CH ;
Gray, MO ;
Zhou, HZ ;
Csukai, M ;
Wu, GY ;
Lorenz, JN ;
Mochly-Rosen, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12798-12803
[10]  
Dunn M J, 1997, Methods Mol Biol, V64, P25